In a new study, the experimental cancer vaccine Provenge boosted the three-year survival of patients with advanced prostate cancer by 38 percent compared with a placebo. Researchers say the patients in the 512-subject study who received the drug, called Provenge, lived an average 4.1 months longer than those who did not receive the medication. One scientist on the study team said that if the drug becomes commercially available in the United States, he has "no doubt...it will replace...
Read moreAfter a patient has been diagnosed with prostate cancer, and treatment options are discussed, some of the most common concerns of the... Read more »
In this era of minimally invasive medicine, High Intensity Focused Ultrasound (HIFU) deserves mention as a suitable option for ablative... Read more »
Prostate cancer is the sixth most common cancer in the world and the second leading cause of cancer death in American men. Almost a quarter... Read more »
For those with prostate cancer that has metastasized (spread) to the bone (like me)... we are praying that Hormone Therapy will prolong our... Read more »
Two news bulletins that hit the health news scene: (1) Chemotherapy may be a new and viable treatment option for Testicular Seminoma -... Read more »
New research suggests that freezing the prostate may be as effective a treatment as radiation and other common therapies. The procedure--called... Read more »
Scientists in Illinois say they've developed a cancer drug that is 200 times more effective than similar medications. Zoledronate is a... Read more »
Source: ADAM Encyclopedia
Radiation TherapyRadiation therapy may be used as an initial treatment for localized prostate cancer. It may also be used as treatment for cancer... Read more »
Source: Agency for Healthcare Research and Quality
Treating Prostate Cancer A Guide for Men With Localized Prostate Cancer Most men have time to learn about all the options for treating their prostate... Read more »
Source: ADAM Encyclopedia
Treatment choices are generally based on the patient's age, the stage and grade of the cancer, overall health status, and the patient's personal... Read more »